Erratum: Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: A randomized trial (Lancet (October 21, 2000) (1384))

Lancet

Volumn 356, Issue SUPPL., 2000, Pages 2196-

  Bergh, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL;

EID: 0034515768     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Erratum

References (0)